Symposium Proposals

We hope you received our recent “Save the Date” email announcing the 9th International CAA Conference to be held in Munich, Germany, October 15-17, 2024. This meeting, which will be held as an on site (in person) format only, comes at a time of great progress towards improved diagnosis and potential disease-modifying treatment of CAA.

We offer you the opportunity to suggest symposium ideas for the Munich ICAA conference. Please contemplate which areas related to the science or clinical manifestations of cerebrovascular amyloid would be of particular interest for you and colleagues from different fields of CAA research. To submit a proposal, please complete the attached document listing the proposed symposium title, a brief introduction, and list of proposed talk titles and speakers. Each symposium should have between 2-4 speakers. You don’t need to contact potential speakers (although you are welcome to do so).  

The ICAA Conference scientific organizing committee consisting of Charlotte Cordonnier, Steven Greenberg, Julie Schneider, Eric Smith, Mark van Buchem, Susanne van Veluw, and Marcel Verbeek will review all submissions.

Please note that the organizing committee may make changes to the proposed symposia or combine parts of various proposals into a single symposium. 

The timeline for submissions is March 1, 2024. 

On behalf of the Conference Scientific and Local Organizing Committees 

Martin Dichgans, MD
Steven M. Greenberg, MD PhD
Marco Düring, MD

Note: The submission form can be accessed here:

Call for Symposium Proposal

Please return your form to: 

You will be asked for a session title, brief introduction (<100 words), titles for up to 4 talks, and primary and alternate speakers for each talk.  We encourage proposals related to the full range of topics in the cerebral amyloid angiopathy and small vessel brain disease fields, including diagnosis, neuroimaging, clinical features, candidate treatments, neuropathology, genetics, animal models, vascular biology, molecular mechanisms, amyloid biology, and vascular physiology.